Lattice Biotech, LLC — Form D/A
Lattice Biotech, LLC of Athens, OH, a company, filed a Form D amendment with the SEC on 2017-02-28. The offering totals $8.0M, of which $512K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-02-28
- Form: D/A
- Accession: 0001667964-17-000001
- Industry: Pharmaceuticals
- Exemptions: 04
- Total offering: $8.0M
- Amount sold: $512K
- Remaining: $7.5M
- Minimum investment: $5K
- Investors: 25
- Date of first sale: 2015-06-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-258271
Issuer
- Name: Lattice Biotech, LLC
- CIK: 0001667964
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 340 West State Street, Suite 212, Athens, OH, 45701
- Phone: 614-915-0865
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Nick Deslar Henderson | Executive Officer | Athens, OH |
| Joseph Deslar Kittle | Executive Officer | Athens, OH |
| Noel Douglas Martin | Executive Officer | Athens, OH |
Other filings by this issuer (1)
More